Moderna Inc (MRNA)
125.00
-0.59
(-0.47%)
USD |
NASDAQ |
May 03, 16:00
125.43
+0.43
(+0.34%)
After-Hours: 20:00
Moderna Accounts Payable (Quarterly): 183.00M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 183.00M |
December 31, 2023 | 520.00M |
September 30, 2023 | 494.00M |
June 30, 2023 | 310.00M |
March 31, 2023 | 389.00M |
December 31, 2022 | 487.00M |
September 30, 2022 | 330.00M |
June 30, 2022 | 181.00M |
March 31, 2022 | 199.00M |
December 31, 2021 | 302.00M |
September 30, 2021 | 87.00M |
June 30, 2021 | 77.00M |
Date | Value |
---|---|
March 31, 2021 | 8.00M |
December 31, 2020 | 18.00M |
September 30, 2020 | 20.52M |
June 30, 2020 | 18.82M |
March 31, 2020 | 11.03M |
December 31, 2019 | 7.09M |
September 30, 2019 | 11.74M |
June 30, 2019 | 29.61M |
March 31, 2019 | 38.51M |
December 31, 2018 | 31.21M |
September 30, 2018 | 24.36M |
December 31, 2017 | 20.72M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
7.09M
Minimum
Dec 2019
520.00M
Maximum
Dec 2023
184.19M
Average
134.00M
Median
Accounts Payable (Quarterly) Benchmarks
Merck & Co Inc | 3.922B |
Pfizer Inc | 6.71B |
Eli Lilly and Co | 2.474B |
Johnson & Johnson | 8.174B |
Novavax Inc | 132.61M |